The Epidemiology of Selenium and Human Cancer

Natural Antioxidants in Human Health and Disease

Volumn , Issue , 2012, Pages 263-286

  Garland, Miriam ^a   Stampfer, Meir J ^a,b   Willett, Walter C ^a,b   Hunter, David J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941053291     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-057168-3.50015-1     Document Type: Chapter

References (96)

1. Agency for Toxic Substances and Disease Registry (ATSDR) (1989). "Toxicological Profile for Selenium," ATSDR Rep. ATSDR/TP 89/21. ATSDR, Atlanta.
2. Batieha A.M., Armenian H.K., Norkus E.P., Morris J.S., Spate V.E., Comstock G.W. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol. Biomarkers Prev. 1993, 2:335-339.
3. Blot W.J., Li J.-Y., Taylor P.R., Guo W., Dawsey S., Wang G.-Q., Yang C.S., Zheng S.-F., Gail M., Li G.-Y., Yu Y., Liu B., Tangrea J., Sun Y., Liu F., Fraumeni J.F., Zhang Y.-H., Li B. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 1993, 85:1483-1492.
4. Bratakos M.S., Vouterakos T.P., Ioannou P.V. Selenium status of cancer patients in Greece. Sci. Total Environ. 1990, 92:207-222.
5. Brock K.E., Gridley G., Morris J.S., Willett W.C. Serum selenium level in relation to in situ cervical cancer in Australia. J. Natl. Cancer Inst. 1991, 83:292-293.
6. Broghamer W.L., McConnell K.P., Grimaldi M., Blotcky A.J. Serum selenium and reticuloendothelial tumors. Cancer (Philadelphia) 1978, 41:1462-1466.
7. Burk R.F. Selenium in man. "Trace Elements in Human Health and Disease" 1976, 105-133. Academic Press, New York. A.S. Prasad, D. Oberleas (Eds.).
8. Burney P.G.J., Comstock G.W., Morris J.S. Serologic precursors of cancer: Serum micronutrients and the subsequent risk of pancreatic cancer. Am. J. Clin. Nutr. 1989, 49:895-900.
9. Calautti P., Moschini G., Stievano B.M., Tomio L., Calzavara F., Perona G. Serum selenium levels in malignant lymphoproliferative diseases. Scand. J. Haematol. 1980, 24:63-66.
10. Cavalieri R.R., Scott K.G., Sairenji E. Selenite (75Se) as a tumor-localizing agent in man. J. Nucl. Med. 1966, 7:197-208.
11. Cech I., Holguin A., Sokolow H., Smith V. Selenium availability in Texas: Possible clinical significance. South. Med. J. 1984, 77:1415-1420.
12. Chaitchik S., Shenberg C., Nir-El Y., Mantel M. The distribution of selenium in human blood samples of Israeli population: Comparison between normal and breast cancer cases. Biol. Trace Elem. Res. 1988, 15:205-212.
13. Clark L.C., Combs G.F. Selenium compounds and the prevention of cancer: Research needs and public health implications. J. Nutr. 1986, 116:170-173.
14. Clark L.C., Graham G.F., Crounse R.G., Grimson R., Hulka B., Shy C.M. Plasma selenium and skin neoplasms: A case-control study. Nutr. Cancer 1984, 6:13-21.
15. Clark L., Graham G., Bray J. Nonmelanoma skin cancer and plasma selenium: A prospective cohort study. Am. J. Epidemiol. 1985, 122:528. (Abstr.).
16. Clark L.C., Cantor K.P., Allaway W.H. Selenium in forage crops and cancer mortality in U.S. counties. Arch. Environ. Health 1991, 46:37-42.
17. Clark L.C., Hixson L.J., Coombs G.F., Reid M.E., Turnbull B.W., Sampliner R.E. Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol. Biomarkers Prev. 1993, 2:41-46.
18. Coates R.J., Weiss N.S., Daling J.R., Morris J.S., Labbe R.F. Serum levels of selenium and retinol and the subsequent risk of cancer. Am. J. Epidemiol. 1988, 128:515-523.
19. Combs G.F., Clark L.C. Can dietary selenium modify cancer risk?. Nutr. Rev. 1985, 43:325-331.
20. Dworkin B.M., Rosenthal W.S., Mittelman A., Weiss L., Applebee-Brady L., Arlin Z. Selenium status and the polyp-cancer sequence: A colonoscopically controlled study. Am. J. Gastroenterol. 1988, 83:748-751.
21. Fex G., Pettersson B., Akesson B. Low plasma selenium as a risk factor for cancer death in middle-aged men. Nutr. Cancer 1987, 10:221-229.
22. Garland M., Morris J.S., Stampfer M.J., Colditz G., Rosner B., Speizer F.E., Willett W.C., Hunter D.J. Prospective study of selenium and cancer among women (abstract). Am. J. Epidemiol. 1993, 138:625.
23. Gerber M., Richardson S., Salkeld R., Chappuis P. Antioxidants in female breast cancer patients. Cancer Invest. 1991, 9:421-428.
24. Gibson R.S. "Principles of Nutritional Assessment," 1990, 511-576. Oxford Univ. Press, New York.
25. Glattre E., Thomassen Y., Thoresen S.O., Haldorsen T., Lund-Larsen P.G., Theodorsen L., Aaseth J. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int. J. Epidemiol. 1989, 18:45-49.
26. Goodwin W.J., Lane H.W., Bradford K., Marshall M.V., Griffin A.C., Geopfert H., Jesse R.H. Selenium and glutathione peroxidase levels in patients with epidermoid carcinoma of the oral cavity and oropharynx. Cancer (Philadelphia) 1983, 51:110-115.
27. Guo W., Li J.-Y., Blot W.J., Hsing A.W., Chen J., Fraumeni J.F. Correlations of dietary intake and blood nutrient levels with esophageal cancer mortality in China. Nutr. Cancer 1990, 13:121-127.
28. Hardell L., Danell M., Angqvist C.-A., Marklund S.L., Fredriksson M., Zakari A.-L., Kjellgren A. Levels of selenium in plasma and glutathione peroxidase in erythrocytes and the risk of breast cancer. Biol. Trace Elem. Res. 1993, 36:99-108.
29. Helzlsouer K.J., Comstock G.W., Morris J.S. Selenium, lycopene, α-tocopherol, β-carotene, retinol, and subsequent bladder cancer. Cancer Res. 1989, 49:6144-6148.
30. Hennekens C.H., Buring J.E. Methodologic considerations in the design and conduct of randomized trials: The U.S. Physicians' Health Study. Controlled Clin. Trials 1989, 10:142S-150S.
31. Hojo Y. Subject groups high and low in urinary selenium levels: Workers exposed to heavy metals and patients with cancer and epilepsy. Bull. Environ. Contam. Toxicol. 1981, 26:466-471.
32. Hunter D.J. Biochemical indicators of dietary intake. "Nutritional Epidemiology" 1990, 143-216. Oxford Univ. Press, New York. W. Willett (Ed.).
33. Hunter D.J., Morris J.S., Chute C.G., Kushner E., Colditz G.A., Stampfer M.J., Speizer F.E., Willett W.C. Predictors of selenium concentration in human toenails. Am. J. Epidemiol. 1990, 132:114-122.
34. Hunter D.J., Morris J.S., Stampfer M.J., Colditz G.A., Speizer F.E., Willett W.C. A prospective study of selenium status and breast cancer risk. J. Am. Med. Assoc. 1990, 264:1128-1131.
35. Ip C. The chemopreventive role of selenium in carcinogenesis. J. Am. Coll. Toxicol. 1986, 5:7-20.
36. Jansson B. Geographic mappings of colorectal cancer rates: A retrospect of studies, 1974-1984. Cancer Detect. Prev. 1985, 8:341-348.
37. Jaskiewicz K., Marasas W.F.O., Rossouw J.E., Van Niekerk F.E., Heine Tech E.W.P. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer (Philadelphia) 1988, 62:2635-2639.
38. Knekt P., Aromaa A., Maatela J., Alfthan G., Aaran R.-K., Hakama M., Hakulinen T., Peto R., Teppo L. Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst. 1990, 82:864-868.
39. Knekt P., Aromaa A., Maatela J., Alfthan G., Aaran R.-K., Nikkari T., Hakama M., Hakulinen T., Teppo L. Serum micronutrients and risk of cancers of low incidence in Finland. Am. J. Epidemiol. 1991, 134:356-361.
40. Knekt P., Jarvinen R., Seppanen R., Rissanen A., Aromaa A., Heinonen O.P., Albanes D., Heinonen M., Pukkula E., Teppo L. Dietary antioxidants and the risk of lung cancer. Am. J. Epidemiol. 1991, 134:471-479.
41. Kneller R.W., Guo W.-D., Hsing A.W., Chen J.-S., Blot W.J., Li J.-Y., Forman D., Fraumeni J.F. Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiol. Biomarkers Prev. 1992, 1:113-118.
42. Kok F.J., De Bruijn A.M., Hofman A., Vermeeren R., Valkenburg H.A. Is serum selenium a risk factor for cancer in men only?. Am. J. Epidemiol. 1987, 125:12-16.
43. Krsnjavi H., Beker D. Selenium in serum as a possible parameter for assessment of breast disease. Breast Cancer Res. Treat. 1990, 16:57-61.
44. Levander O.A. The need for measures of selenium status. J. Am. Coll. Toxicol. 1986, 5:37-44.
45. Linder M.C. "Nutritional Biochemistry and Metabolism with Clinical Applications," 1991, 243-246. Elsevier, New York.
46. Longnecker M.P., Stampfer M.J., Morris J.S., Spate V., Baskett C., Mason M., Willett W.C. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am. J. Clin. Nutr. 1993, 57:408-413.
47. McConnell K.P., Broghamer W.L., Blotcky A.J., Hurt O.J. Selenium levels in human blood and tissues in health and in disease. J. Nutr. 1975, 105:1026-1031.
48. McConnell K.P., Jager R.M., Bland K.I., Blotcky A.J. The relationship of dietary selenium and breast cancer. J. Surg. Oncol. 1980, 15:67-70.
49. Medina D. Mechanisms of selenium inhibition of tumorigenesis. J. Am. Coll. Toxicol. 1986, 5:21-27.
50. Menkes M.S., Comstock G.W., Vuilleumier J.P., Helsing K.J., Rider A.A., Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N. Engl. J. Med. 1986, 315:1250-1254.
51. Meyer F., Verreault R. Erythrocyte selenium and breast cancer risk. Am. J. Epidemiol. 1987, 125:917-919.
52. Mikac-Devic M., Ferenee D., Tiefenbach A. Serum selenium levels in untreated children with acute lymphoblastic leukemia. I. J. Trace Elem. Electrolytes Health Dis. 1990, 4:7-10.
53. Mikac-Devic M., Vukelic N., Kljaic K. Serum selenium levels in patients with colorectal cancer. Biol. Trace Elem. Res. 1992, 33:87-94.
54. Nomura A., Heilbrun L.K., Morris J.S., Stemmermann G.N. Serum selenium and the risk of cancer, by specific sites: Case-control analysis of prospective data. J. Natl. Cancer Inst. 1987, 79:103-108.
55. Overvad K., Grøn P., Langhoff O., Tarp U., Foldspang A., Thorling E.B. Selenium in human mammary carcinogenesis: A case-referent study. Eur. J. Cancer Prev. 1991, 1:27-30.
56. Overvad K., Wang D.Y., Olsen J., Allen D.S., Thorling E.B., Bulbrook R.D., Hayward J.L. Selenium in human mammary carcinogenesis: A case-cohort study. Eur. J. Cancer 1991, 27:900-902.
57. Pawlowicz Z., Zachara B.A., Trafikowska V., Maciag A., Marchaluk E., Nowicki A. Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer. J. Trace Elem. Electrolytes Health Dis. 1991, 5:275-277.
58. Peleg I., Morris S., Hames C.G. Is serum selenium a risk factor for cancer?. Med. Oncol. Tumor Pharmacother. 1985, 2:157-163.
59. Poole, C. (1989). Cancer and high selenium intake. Ph.D. thesis. Harvard Sch. of Public Health, Boston.
60. Pothier L., Lane W.W., Bhargava A., Michielson C., Douglass H.O. Plasma selenium levels in patients with advanced upper gastrointestinal cancer. Cancer (Philadelphia) 1987, 60:2251-2260.
61. Reinhold U., Biltz H., Bayer W., Schmidt K.H. Serum selenium levels in patients with malignant melanoma. Acta Derm.-Venereol. 1989, 69:132-136.
62. Ringstad J., Jacobsen B.K., Tretli S., Thomassen Y. Serum selenium concentration associated with risk of cancer. J. Clin. Pathol. 1988, 41:454-457.
63. Robinson M.F., Godfrey P.J., Thomson C.D., Rea H.M., van Rij A.M. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am. J. Clin. Nutr. 1979, 32:1477-1485.
64. Rogers M.A.M., Thomas D.B., Davis S., Weiss N.S., Vaughan T.L., Nevissi A.E. A case-control study of oral cancer and pre-diagnostic concentrations of selenium and zinc in nail tissue. Int. J. Cancer 1991, 48:182-188.
65. Salonen J.T., Alfthan G., Huttunen J.K., Puska P. Association between serum selenium and the risk of cancer. Am. J. Epidemiol. 1984, 120:342-349.
66. Salonen J.T., Salonen R., Lappetelainen R., Maenpaa P.H., Alfthan G., Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: Matched case-control analysis of prospective data. Br. Med. J. 1985, 290:417-420.
67. Schober S.E., Comstock G.W., Helsing K.J., Salkeld R.M., Morris J.S., Rider A.A., Brookmeyer R. Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. Am. J. Epidemiol. 1987, 126:1033-1041.
68. Schrauzer G.N., White D.A., Schneider C.J. Cancer mortality correlation studies. III: Statistical associations with dietary selenium intakes. Bioinorg. Chem. 1977, 7:23-34.
69. Schrauzer G.N., Molenaar T., Mead S., Kuehn K., Yamamoto H., Araki E. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn. J. Cancer Res. 1985, 76:374-377.
70. Shamberger R.J., Rukovena E., Longfield A.K., Tytko S.A., Deodhar S., Willis C.E. Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J. Natl. Cancer Inst. 1973, 50:863-870.
71. Shamberger R.J., Tytko S.A., Willis C.E. Antioxidants and cancer. IV: Selenium and age-adjusted human cancer mortality. Arch. Environ. Health 1976, 31:231-235.
72. Slattery M.L., Abbott T.M., Overall J.C., Robison L.M., French T.K., Jolles C., Gardner J.W., West D.W. Dietary vitamins A, C, and E and selenium as risk factors for cervical cancer. Epidemiology 1990, 1:8-15.
73. Stampfer M.J., Colditz G.A., Willett W.C. The epidemiology of selenium and cancer. Cancer Surv. 1987, 6:623-633.
74. Sundstrom H., Yrjanheikki E., Kauppila A. Low serum selenium concentration in patients with cervical or endometrial cancer. Int. J. Gynaecol. Obstet. 1984, 22:35-40.
75. Sundstrom H., Yrjanheikki E., Kauppila A. Serum selenium in patients with ovarian cancer during and after therapy. Carcinogenesis 1984, 5:731-734.
76. Sundstrom H., Ylikorkala O., Kauppila A. Serum selenium and thromboxane in patients with gynaecological cancer. Carcinogenesis 1986, 7:1051-1052.
77. Toma S., Micheletti A., Giacchero A., Coialbu T., Collecchi P., Esposito M., Rotondi M., Albanese E., Cantoni E. Selenium therapy in patients with precancerous and malignant oral cavity lestions: Preliminary results. Cancer Detect. Prev. 1991, 15:491-494.
78. Tominaga K., Saito Y., Mori K., Miyazawa N., Yolio K., Koyama Y., Shimamura K., Imura J., Nagai M. An evaluation of serum microelement concentrations in lung cancer and matched non-cancer patients to determine the risk of developing lung cancer: A preliminary study. Jpn. J. Clin. Oncol. 1992, 22:96-101.
79. Trush M.A., Kensler T.W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radicals Biol. Med. 1991, 10:201-209.
80. van den Brandt P.A., Goldbohm R.A., van't Veer P., Bode P., Dorant E., Hermus R.J.J., Sturmans F. A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J. Natl. Cancer Inst. 1993, 85:224-229.
81. van den Brandt, P. A., Goldbohm, R. A., van't Veer, P., Bode, P., Dorant, E., Hermus, R. J. J., and Sturmans, F. (1993b). Toenail selenium levels and the subsequent risk of breast cancer. Ph.D. thesis. Univ. of Limburg, Maastricht, Netherlands.
82. van den Brandt P.A., Goldbohm R.A., van't Veer P., Bode P., Dorant E., Hermus R.J.J., Sturmans F. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res. 1993, 53:4860-4865.
83. van Noord P.A.H., Collette H.J.A., Maas M.J., de Waard F. Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int. J. Epidemiol. 1987, 16:318-322. Suppl.
84. van Noord P.A.H., Maas M.J., van der Tweel I., Collette C. Selenium and the risk of postmenopausal breast cancer in the DOM cohort. Breast Cancer Res. Treat. 1993, 25:11-19.
85. van't Veer P., Van der Wielen R.P.J., Kok F.J., Hermus R.J.J., Sturmans F. Selenium in diet, blood, and toenails in relation to breast cancer: A case-control study. Am. J. Epidemiol. 1990, 131:987-994.
86. Vernie L.N., De Vries M., Benckhuijsen C., De Goeij J.J.M., Zegers C. Selenium levels in blood and plasma, and glutathione peroxidase activity in blood of breast cancer patients during adjuvant treatment with cyclophosphamide, methotrexate and 5-fluorouracil. Cancer Lett. 1983, 18:283-289.
87. Virtamo J., Valkeila E., Alfthan G., Punsar S., Huttunen J.K., Karvonen M.J. Serum selenium and risk of cancer: A prospective follow-up of nine years. Cancer (Philadelphia) 1987, 60:145-148.
88. West D.W., Slattery M.L., Robison L.M., French T.K., Mahoney A.W. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 1991, 2:85-94.
89. Willett W.C., Stampfer M.J. Selenium and human cancer. Acta Pharmacol. Toxicol. 1986, 59(Suppl. VII):240-247.
90. Willett W.C., Stampfer M.J. Selenium and human cancer: Epidemiological aspects and implications for clinical trials. J. Am. Coll. Toxicol. 1986, 5:29-36.
91. Willett W.C., Polk B.F., Morris J.S., Stampfer M.J., Pressel S., Rosner B., Taylor J.O., Schneider K., Hames C.G. Prediagnostic serum selenium and risk of cancer. Lancet 1983, ii:130-134.
92. Willett W.C., Stampfer M.J., Hunter D., Colditz G.A. The epidemiology of selenium and human cancer. "Trace Elements in Health and Disease" 1991, 141-155. R. Soc. Chem., Cambridge, England. A. Aitio, A. Aro (Eds.).
93. Yang R., Huang J., Feng G., Mei Z. Blood selenium levels in nasopharyngeal cancer patients in south China. Med. Lab. Sci. 1990, 47:132-134.
94. Yu S., Chu Y., Gong X., Hou C. Regional variation of cancer mortality incidence and its relation to selenium levels in China. Biol. Trace Elem. Res. 1985, 7:21-29.
95. Yu S., Zhu Y., Li W., Huang Q., Zhi-Huang C., Zhang Q., Hou C. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol. Trace Elem. Res. 1991, 29:289-294.
96. Zheng W., Blot W.J., Diamond E.L., Norkus E.P., Spate V., Morris J.S., Comstock G.W. Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Res. 1993, 53:795-798.